Goosed - UKRI Covid vaccine assessment criteria7 Jul 2020 14:53
Stolen goosed post from ADVFN, hope he doesn't mind, to do with UKRI funding for Covid vaccines, but i thought his last point was interesting:
"07/7/2020 09:53
The only way to find out as ever is through the trial process & that requires funding. The UKRI MRC Covid-19 first & second funding calls have omitted to fund the Nottingham Uni's/Scancell collaboration. Https://mrc.ukri.org/funding/browse/ukri-nihr-covid-19/ukri-nihr-covid-19-rolling-call/ However "We are now launching a subsequent, rolling call for rapid research proposals with potential to deliver public health impacts within 12 months." Clutching at straws maybe but amongst the assessment criteria is "Alignment with WHO-Roadmap priorities" . . . . perhaps one more box ticked. gooosed"
Here's the evaluation criteria:
https://mrc.ukri.org/funding/browse/ukri-nihr-covid-19/ukri-nihr-covid-19-rolling-call/
"Evaluation process
Proposals will be reviewed firstly by members of a college of experts, chosen based on the subject matter of the proposal. These reviews will then be used by an Expert Panel, who will make recommendations on outcome to UKRI and DHSC. Applicants will not have an opportunity to respond to Panel comments in instances where feedback is provided, except where clarifications and/or changes are required as part of the award process.
Key assessment criteria for the submissions will include:
- The potential for the proposal to have an impact the within the period of the award and to provide a unique value-adding contribution relative to existing activity
- Access to required resources
- Applicant expertise and experience
- Partnership: including strength and clarity of collaborations and opportunities provided
- Design and feasibility of project plan
- Value for money
- Alignment with WHO-Roadmap priorities"
So perhaps being on the WHO official list is more significant than it first appears?
P.s. I'm guessing Nottingham/Scancell tick most the other boxes? The "Access to required resources" seems a strange one though? Isn't that point of the funding?
Sign In
Follow the stocks
